NeuroOne Medical Technologies Corporation Stock Other OTC
Equities
NMTC
US64130M1009
Advanced Medical Equipment & Technology
Sales 2022 | 2.12 2.9 | Sales 2023 | 3.41 4.66 | Capitalization | 21.3M 29.14M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.68M | Net income 2023 | -11M -15.05M | EV / Sales 2022 | 7,761,717 x |
Net cash position 2022 | 10.94M 14.97M | Net cash position 2023 | 5.14M 7.03M | EV / Sales 2023 | 4,742,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.9% |
Latest transcript on NeuroOne Medical Technologies Corporation
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 09-08-19 |
David Rosa
CEO | Chief Executive Officer | 59 | 17-07-19 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 17-08-03 |
Director/Board Member | 63 | 17-08-03 | |
Edward Andrle
BRD | Director/Board Member | 66 | 20-02-17 |
1st Jan change | Capi. | |
---|---|---|
-12.42% | 19.08B | |
-46.59% | 2.65B | |
+17.50% | 1.87B | |
-0.58% | 1.61B | |
+25.36% | 1.21B | |
-8.67% | 1.02B | |
-21.91% | 905M | |
-4.42% | 716M | |
-17.51% | 682M |